600267.SHG Zhejiang Hisun Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Shanghai Stock Exchange
13.64 CNY
Close of Nov 4, 2026
9.35 15.00
Market cap
CNY 16.1B
P/E
12.4x
P/B
1.58x
ROE
16.1%
Dividend yield
2.13%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is 600267.SHG undervalued?

Graham number
Price13.64
Graham value14.60
Discount6.6%

600267.SHG trades 6.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Zhejiang Hisun Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Zhejiang Hisun Pharmaceutical Co Ltd yet.

Zhejiang Hisun Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Zhejiang Hisun Pharmaceutical Co Ltd

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients. It also offers its products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, and orthopedics treatment; nutrition and healthcare; and oncology, ADC small molecule, animal healthcare, and others. The company exports its products to approx…

Full company profile